{
  "abstract": "Annexin A2 (ANXA2) is involved in cell-surface fibrinolysis and has been associated with hepatocellular carcinoma (HCC). We examined ANXA2 expression in HCC and its associations with survival and immune–hemostatic gene expression. ANXA2 transcript expression was assessed in The Cancer Genome Atlas liver cancer cohort (TCGA-LIHC) and an independent HCC dataset (GSE25097). Public protein datasets were used to examine ANXA2 abundance. We analyzed clinicopathological associations, overall survival, tumor–normal tissue discrimination, and correlations with selected immune, coagulation, fibrinolytic, and inflammatory genes. ANXA2 expression was higher in HCC than in non-tumor liver tissue in the transcriptomic analyses and was elevated in the protein analyses. Higher ANXA2 expression was associated with poorer overall survival after adjustment for age, sex, and pathological stage (hazard ratio, 1.26; 95% confidence interval, 1.07–1.49; p = 0.006). Within TCGA-LIHC, ANXA2 expression discriminated tumor from normal tissue (area under the curve, 0.895; 95% confidence interval, 0.852–0.933); this performance was not independently validated. ANXA2 expression also correlated with selected fibrinolytic, inflammatory, and immune-related genes. GSE25097 supported the differential-expression finding. ANXA2 is overexpressed in HCC and is associated with poorer survival and an immune–hemostatic transcriptional pattern. The correlations do not establish that ANXA2 regulates these processes.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia",
    "Department of Biology, College of Sciences, King Khalid University, P.O. Box 960, Abha 61413, Saudi Arabia",
    "Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Esra’a Abudouleh",
      "orcid": "0000-0002-8922-0143"
    },
    {
      "affs": [
        0
      ],
      "name": "Rasha Elsayim"
    },
    {
      "affs": [
        1
      ],
      "name": "Heba W. Alhamdi",
      "orcid": "0000-0002-1908-9469"
    },
    {
      "affs": [
        2
      ],
      "name": "Nada Fahad Almebairik"
    },
    {
      "affs": [
        0
      ],
      "name": "Noorah A. Alkubaisi",
      "orcid": "0000-0001-8847-323X"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/2a1hq1h04zpkz.bib",
  "cited_by": 0,
  "doi": "10.3390/ijms27198915",
  "fulltext_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13666242/?tool=EBI",
  "id": "2a1hq1h04zpkz",
  "issns": [
    "1422-0067"
  ],
  "landing_url": "https://europepmc.org/article/PMC/PMC13666242",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2721|Hepatocellular Carcinoma Treatment and Prognosis"
    ]
  ],
  "openalex": "W7221068748",
  "pdf_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13666242/pdf/?tool=EBI",
  "pmcid": "PMC13666242",
  "pmid": null,
  "published": "2026-10-01",
  "publisher": "MDPI AG",
  "ris": "https://research.draconitic.com/paper/2a1hq1h04zpkz.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:31Z",
      "native_id": "PMC:PMC13666242",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13666242"
    },
    {
      "first_seen": "2026-10-30T12:18:55Z",
      "native_id": "10.3390/ijms27198915",
      "source": "crossref",
      "url": "https://www.mdpi.com/1422-0067/27/19/8915"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2721|Hepatocellular Carcinoma Treatment and Prognosis",
      "subfield": "general"
    }
  ],
  "title": "ANXA2 as a Candidate Molecular Hub Linking Fibrinolysis, Coagulation, and Immune Remodeling in Hepatocellular Carcinoma: An Integrative Multi-Omics Analysis",
  "title_text": "ANXA2 as a Candidate Molecular Hub Linking Fibrinolysis, Coagulation, and Immune Remodeling in Hepatocellular Carcinoma: An Integrative Multi-Omics Analysis",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:18:55Z",
  "url": "https://research.draconitic.com/paper/2a1hq1h04zpkz",
  "venue": "International journal of molecular sciences",
  "versions": []
}